Follow
Haleh Hamedifar
Haleh Hamedifar
1- CinnaGen Medical Biotechnology Research Center, Alborz University of Medical sciences, Karaj
Verified email at cinnagen.com - Homepage
Title
Cited by
Cited by
Year
Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management
AU Anka, MI Tahir, SD Abubakar, M Alsabbagh, Z Zian, H Hamedifar, ...
Scandinavian journal of immunology 93 (4), e12998, 2021
3422021
A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders
AN Kamali, SM Noorbakhsh, H Hamedifar, F Jadidi-Niaragh, R Yazdani, ...
Molecular immunology 105, 107-115, 2019
1592019
Biscoumarin-1, 2, 3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies
MS Asgari, M Mohammadi-Khanaposhtani, M Kiani, PR Ranjbar, E Zabihi, ...
Bioorganic chemistry 92, 103206, 2019
752019
Synthesis and biological evaluation of new benzimidazole-1, 2, 3-triazole hybrids as potential α-glucosidase inhibitors
N Asemanipoor, M Mohammadi-Khanaposhtani, S Moradi, M Vahidi, ...
Bioorganic chemistry 95, 103482, 2020
612020
A review on synthesis, mechanism of action, and structure-activity relationships of 1, 2, 3-triazole-based α-glucosidase inhibitors as promising anti-diabetic agents
Z Fallah, M Tajbakhsh, M Alikhani, B Larijani, MA Faramarzi, H Hamedifar, ...
Journal of Molecular Structure 1255, 132469, 2022
542022
Synthesis, characterization, molecular docking, and biological activities of coumarin–1, 2, 3‐triazole‐acetamide hybrid derivatives
N Sepehri, M Mohammadi‐Khanaposhtani, N Asemanipoor, S Hosseini, ...
Archiv der Pharmazie 353 (10), 2000109, 2020
512020
Synthesis and pharmacological properties of polysubstituted 2-amino-4H-pyran-3-carbonitrile derivatives
Z Tashrifi, M Mohammadi-Khanaposhtani, H Hamedifar, B Larijani, ...
Molecular Diversity 24, 1385-1431, 2020
442020
The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases
SPDG Berry, C Dossou, A Kashif, N Sharifinejad, G Azizi, H Hamedifar, ...
International Immunopharmacology 102, 108402, 2022
422022
Synthesis and characterization of γ-Fe 2 O 3@ SiO 2–(CH 2) 3–PDTC–Pd magnetic nanoparticles: A new and highly active catalyst for the Heck/Sonogashira coupling reactions
Z Tashrifi, S Bahadorikhalili, H Lijan, S Ansari, H Hamedifar, M Mahdavi
New Journal of Chemistry 43 (23), 8930-8938, 2019
332019
Autoimmunity in common variable immunodeficiency: a systematic review and meta-analysis
FS Rizvi, H Zainaldain, H Rafiemanesh, M Jamee, N Hossein-Khannazer, ...
Expert review of clinical immunology 16 (12), 1227-1235, 2020
322020
Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS‐like diseases: A systematic review
N Hafezi, M Zaki‐Dizaji, M Nirouei, G Asadi, N Sharifinejad, M Jamee, ...
Pediatric Allergy and Immunology 32 (7), 1519-1532, 2021
262021
A new series of Schiff base derivatives bearing 1, 2, 3‐triazole: Design, synthesis, molecular docking, and α‐glucosidase inhibition
E Nasli‐Esfahani, M Mohammadi‐Khanaposhtani, S Rezaei, Y Sarrafi, ...
Archiv der Pharmazie 352 (8), 1900034, 2019
262019
The potential role of pro-inflammatory and anti-inflammatory cytokines in epilepsy pathogenesis
AN Kamali, Z Zian, JM Bautista, H Hamedifar, N Hossein-Khannazer, ...
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2021
232021
Clinical, immunological, and genetic features in 938 patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a systematic review
N Sharifinejad, M Zaki-Dizaji, S Tebyanian, H Zainaldain, M Jamee, ...
Expert Review of Clinical Immunology 17 (8), 807-817, 2021
232021
Design, synthesis and biological evaluation of novel phthalimide-Schiff base-coumarin hybrids as potent α-glucosidase inhibitors
M Sherafati, M Mohammadi-Khanaposhtani, S Moradi, MS Asgari, ...
Chemical Papers 74, 4379-4388, 2020
222020
α-Glucosidase and α-amylase inhibition, molecular modeling and pharmacokinetic studies of new quinazolinone-1, 2, 3-triazole-acetamide derivatives
A Yavari, M Mohammadi-Khanaposhtani, S Moradi, S Bahadorikhalili, ...
Medicinal Chemistry Research 30, 702-711, 2021
202021
Design, synthesis, in vitro α-glucosidase inhibition, docking, and molecular dynamics of new phthalimide-benzenesulfonamide hybrids for targeting type 2 diabetes
M Askarzadeh, H Azizian, M Adib, M Mohammadi-Khanaposhtani, ...
Scientific Reports 12 (1), 10569, 2022
182022
Anticancer properties of N-alkyl-2, 4-diphenylimidazo [1, 2-a] quinoxalin-1-amine derivatives; kinase inhibitors
Z Rezaei, MM Didehvar, M Mahdavi, H Azizian, H Hamedifar, ...
Bioorganic Chemistry 90, 103055, 2019
172019
The use of magnetic starch as a support for an ionic liquid-β-cyclodextrin based catalyst for the synthesis of imidazothiadiazolamine derivatives
S Bahadorikhalili, S Ansari, H Hamedifar, M Mahdavi
International journal of biological macromolecules 135, 453-461, 2019
172019
Quinazolinone-dihydropyrano [3, 2-b] pyran hybrids as new α-glucosidase inhibitors: Design, synthesis, enzymatic inhibition, docking study and prediction of pharmacokinetic
M Sherafati, R Mirzazadeh, E Barzegari, M Mohammadi-Khanaposhtani, ...
Bioorganic chemistry 109, 104703, 2021
162021
The system can't perform the operation now. Try again later.
Articles 1–20